دورية أكاديمية

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.

التفاصيل البيبلوغرافية
العنوان: Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study.
المؤلفون: Peled, Nir, Kian, Waleed, Inbar, Edna, Goldstein, Iris M., Zemel, Melanie, Rotem, Ofer, Rozenblum, Anna B., Nechushtan, Hovav, Dudnik, Elizabeth, Levin, Daniel, Zer, Alona, Keren-Rosenberg, Shoshana, Yust-Katz, Shlomit, Fuchs, Vered, Remilah, Areen A., Shelef, Ilan, Roisman, Laila C.
المصدر: Neuro-Oncology Advances; Jan-Dec2022, Vol. 4 Issue 1, p1-11, 11p
قاعدة البيانات: Complementary Index